Novartis (Netherlands)

Recent papers from Novartis (Netherlands)

1. Pivotal trial design considerations for new and next generation cell and gene therapiesJournal of Biopharmaceutical Statistics · 2026
2. Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapyProceedings of the National Academy of Sciences · 2026
3. Results of the multicenter study “Registry of patients with inherited retinal dystrophies caused by confirmed biallelic mutations in the RPE65 and RLBP1 genes in Russia (REGINA)”. Report 1. Molecular genetic characteristics of inherited retinal pathologiesRussian Annals of Ophthalmology · 2026
4. Results of the multicenter study “Registry of patients with inherited retinal dystrophies caused by confirmed biallelic mutations in the RPE65 and RLBP1 genes in Russia (REGINA)”. Report 2. Clinical, social and demographic characteristics of inherited retinal pathologiesRussian Annals of Ophthalmology · 2026
5. A Simple Framework for Collaborative Development of Predictive Models Trained on Proprietary DataJournal of Chemical Information and Modeling · 2025
6. A Simple Framework for Collaborative Development of Predictive Models Trained on Proprietary DataJournal of Chemical Information and Modeling · 2025
7. Liquid-crystal vector vortex coronagraphs for exoplanet imaging: progress from the SUPPPPRESS project2025
8. The ICEDORA study: clinical and demographic characteristics and treatment regimens of patients with HR+ HER2- locally advanced or metastatic breast cancer receiving CDK4/6 inhibitors in real clinical practiceReal-World Data & Evidence · 2025
9. Impact of a clinical decision support system on adherence to clinical guidelines in the management of patients with heart failure (SPHERA-HF study)CARDIOVASCULAR THERAPY AND PREVENTION · 2025
10. Mechanism of SK2 channel gating and its modulation by the bee toxin apamin and small moleculeseLife · 2025
11. Heterogeneous Visual Function Deficits in Intermediate Age-Related Macular Degeneration: A MACUSTAR ReportOphthalmology Science · 2025
12. The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS)Rational Pharmacotherapy in Cardiology · 2024
13. MATISSE, the VLTI mid-infrared spectro-interferometric imager: achievements and perspectives2024
14. Design and performances of the ELT-METIS cryogenic derotator drive2024
15. Development of a monolithic flexure based tip/tilt cryo-mechanism to stabilize the pupil of METIS (Conference Presentation)2024
16. 2024 Update on Position Statement by Experts from the Polish Society of Allergology and the Polish Respiratory Society on the Evaluation of Efficacy and Effectiveness of Single Inhaler Triple Therapies in Asthma Treatment2024
17. Outcomes of COVID-19 in Ofatumumab-treated Patients with RMS: Data from the ALITHIOS Open-label Extension Study (P1-6.010)Neurology · 2024
18. Unveiling the humanistic burden of C3 glomerulopathy in Italy: a narrative medicine multicentre project2024
19. The first Russian register of patients with neovascular age-related macular degeneration: a real-world clinical studyRussian Ophthalmological Journal · 2023
20. Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extensionMultiple Sclerosis Journal · 2023